Circio Holding ASA (0RIS)
LSE
Closed
Oct 8, 2026
Day's Range
10.9352 wk Range
0.9285Overview - 0RIS - Circio Holding ASA
Key Statistics
Valuation
Enterprise Value
2.28B
Price / Book
‪5.44‬
EV / EBITDA
‪-36.29‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-14.11%‬
Return on Equity
‪-25.55%‬
Ownership
Shares Outstanding
52.61M
Float
216.80M
Held by Insiders
‪30.54%‬
Held by Institutions
‪3.63%‬
Price stats
Beta
‪-1.10‬
50-Day Avg
‪24.22‬
200-Day Avg
‪24.22‬
Market Cap - 0RIS - Circio Holding ASA
Peers - 0RIS - Circio Holding ASA
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- 0RISLSECircio Holding ASA541.42MMarket Cap+94.15%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- 0MGBLSEGenmab A/S198.39BMarket Cap+15.12%52-week change33.69P/E (Trailing)‪29.01%‬Profit Margin
- 0QZULSEVertex Pharmaceuticals Incorporated Common Stock128.96BMarket Cap+20.00%52-week change0.53P/E (Trailing)‪34.99%‬Profit Margin
- 0A45LSEModerna Inc.95.05BMarket Cap+87.31%52-week change72.95P/E (Trailing)‪11.32%‬Profit Margin
- 0R2MLSERegeneron Pharmaceuticals, Inc.79.08BMarket Cap+20.99%52-week change0.11P/E (Trailing)‪27.86%‬Profit Margin
- 0QW0LSEargenx SE49.68BMarket Cap+27.60%52-week change40.07P/E (Trailing)‪-47.51%‬Profit Margin
- 0NZTLSEUCB SA41.70BMarket Cap-23.88%52-week change120.47P/E (Trailing)‪6.45%‬Profit Margin
Profile Summary - 0RIS - Circio Holding ASA
About
Circio Holding ASA is a clinical-stage biotechnology company headquartered in Lysaker, Norway, specializing in the development of novel circular RNA (circRNA) therapeutics and immuno-oncology immunotherapies for treatment-resistant cancers and difficult-to-treat diseases. Formerly known as Targovax ASA until its…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
